7Baggers
Quarterly
Annual
    Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 
      
    		                                 
      operating activities
    		                                 
      net income
    		-17,918,000 5,960,000 -11,722,000 -13,156,000 -13,266,000 -18,864,000 -13,273,000 -18,098,000 -7,527,000 -15,167,000 -13,494,000 -11,029,000 -10,643,000 -6,342,000 -6,137,000 -9,928,000 -5,533,000 -6,140,000 -11,475,000 -11,856,000 -12,381,000 -11,135,000 -12,139,000 -7,907,000 -5,306,000 -4,318,000 9,161,000  -7,433,000 -8,479,000 -7,838,000 -6,563,000 -6,089,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                 
      stock-based compensation expense
    		3,989,000 2,803,000 2,654,000 2,621,000 2,552,000 2,469,000 2,555,000 2,335,000 2,289,000 1,460,000 1,638,000 1,545,000 1,597,000 949,000 973,000 1,232,000 986,000 780,000           852,000 700,000 707,000 625,000 348,000 
      amortization of premium/discount on investments
    		-2,734,000 -2,561,000 -2,093,000 -1,674,000 -1,723,000 -1,334,000 43,000 259,000 332,000 304,000 192,000 192,000 218,000 163,000 -2,000 -17,000 -41,000 -86,000 -89,000 -53,000 -132,000 -216,000 -85,000           
      depreciation expense
    		147,000 148,000 146,000 142,000 140,000 145,000 148,000 156,000 148,000 138,000 155,000 162,000 165,000 159,000 140,000 144,000 135,000 124,000 115,000 -76,000 305,000 109,000 109,000 90,000 80,000         
      non-cash interest expense and other
    		                                 
      realized gain on investments
    		-18,000 0 0                               
      changes in operating assets and liabilities:
    		                                 
      accounts receivable
    		123,000 57,000 62,000 383,000 -277,000 -16,000 935,000 -1,185,000 24,868,000                         
      prepaid expenses and other current assets
    		-405,000 1,180,000 -465,000 228,000 -90,000 1,143,000 -790,000 1,035,000 613,000 -1,563,000 596,000 98,000 -2,194,000 -17,000 -360,000 1,255,000 -623,000 4,084,000 -4,077,000 -718,000 303,000 -144,000 752,000           
      operating lease, right-of-use asset
    		193,000 187,000 180,000 174,000 168,000 162,000 158,000                           
      accounts payable and accrued liabilities
    		-3,818,000 4,029,000 5,490,000 1,745,000 -4,745,000 1,980,000 2,019,000 3,409,000 -1,851,000 1,837,000 4,485,000 1,603,000 -1,955,000 785,000 1,191,000 1,538,000 -4,005,000 -4,780,000 3,767,000               
      deferred revenue
    		-6,990,000 -30,687,000 -9,823,000 -8,310,000 -8,719,000 -2,257,000 -7,987,000 -4,106,000 -13,497,000 -1,458,000 36,483,000 -7,194,000 -3,203,000 -5,518,000 -1,663,000 59,812,000 -1,091,000 -634,000 -39,000   -1,000 0 -240,000 -239,000 -128,000        
      operating lease liability
    		-259,000 -242,000 -236,000 -230,000 -220,000 -205,000 -200,000                           
      net cash from operating activities
    		-27,690,000 -18,971,000 -15,798,000 -18,091,000 -26,152,000 -16,786,000 -16,348,000 -16,069,000 5,449,000 -14,729,000 30,134,000 -14,682,000 -15,971,000 -9,349,000 -5,392,000 54,519,000 -9,694,000 -5,671,000 -10,575,000 -7,877,000 -11,223,000 -9,398,000 -7,372,000 -7,215,000 -4,431,000 -5,837,000 891,000 -5,177,000 -7,524,000 -6,547,000 -7,011,000 -5,401,000 -5,726,000 
      capex
    		-19,000 -114,000 -1,000 -279,000 -93,000 -116,000 -55,000 -215,000 -26,000 -49,000 0 -30,000 -39,000 -488,000 -60,000 -198,000 -56,000 -486,000 -135,000 -79,000 -121,000 -9,000 -208,000 -160,000 -118,000 0 0 0 -16,000 -43,000 -31,000 -46,000 -55,000 
      free cash flows
    		-27,709,000 -19,085,000 -15,799,000 -18,370,000 -26,245,000 -16,902,000 -16,403,000 -16,284,000 5,423,000 -14,778,000 30,134,000 -14,712,000 -16,010,000 -9,837,000 -5,452,000 54,321,000 -9,750,000 -6,157,000 -10,710,000 -7,956,000 -11,344,000 -9,407,000 -7,580,000 -7,375,000 -4,549,000 -5,837,000 891,000 -5,177,000 -7,540,000 -6,590,000 -7,042,000 -5,447,000 -5,781,000 
      investing activities
    		                                 
      purchase of investments
    		-75,393,000 -162,088,000 -85,538,000 -69,368,000 -34,353,000 -146,649,000 -37,955,000 -36,103,000 -46,277,000 -33,561,000 -84,446,000 -5,604,000 -9,907,000                     
      maturities of investments
    		72,850,000 49,500,000 85,004,000 98,975,000 62,796,000 38,866,000 63,800,000 42,882,000 8,500,000 29,325,000 21,931,000 26,500,000 3,400,000                     
      purchases of property and equipment
    		-19,000 -114,000 -1,000 -279,000 -93,000 -116,000 -55,000 -215,000 -26,000 -49,000 0 -30,000 -39,000 -488,000 -60,000 -198,000 -56,000 -486,000 -135,000 -79,000 -121,000 -9,000 -208,000 -160,000 -118,000    -16,000 -43,000 -31,000 -46,000 -55,000 
      net cash from investing activities
    		-2,562,000 -112,702,000 -535,000 29,328,000 28,350,000 -107,899,000 25,790,000 6,564,000 -37,803,000 -4,285,000 -62,515,000 20,866,000 -6,546,000 -96,849,000 1,843,000 9,057,000 13,130,000 4,388,000 10,863,000 -17,587,000 19,099,000 9,136,000 15,774,000 3,338,000 3,870,000 1,855,000 -46,629,000 13,149,000 8,265,000 5,841,000 -1,950,000 -27,225,000 -35,136,000 
      financing activities
    		                                 
      adjustments to offering costs
    		-8,000                                 
      repayment of debt
    		 0 0 -2,225,000 -1,200,000 -1,200,000 -1,200,000 -1,200,000 -1,200,000 -1,200,000        0 -333,000 -500,000 -500,000 -500,000            
      proceeds from exercise of stock options, net of taxes paid on vested rsus
    		1,780,000                                 
      proceeds from exercise of warrants
    		17,579,000                                 
      net cash from financing activities
    		19,351,000 156,610,000 1,201,000 8,398,000 -1,087,000 11,543,000 92,816,000 -1,020,000 -650,000 10,873,000 89,680,000 9,000 202,000 -11,000 56,390,000 2,000 5,000,000 0 1,646,000 -509,000 23,118,000 -500,000 -498,000 0 7,000 0  63,000 11,000   62,000 -2,104,000 
      effect of exchange rate on cash and cash equivalents
    		-4,000 17,000 37,000 -24,000 -22,000 -107,000 7,000                           
      net increase in cash and cash equivalents and restricted cash
    		-10,905,000 24,954,000 -15,095,000 19,611,000 1,089,000 -113,249,000    -8,192,000 57,286,000 6,184,000 -22,330,000 -106,116,000 52,855,000 63,642,000 8,323,000 -1,272,000 1,927,000 -25,969,000 30,980,000 -762,000 7,904,000 -3,877,000 -554,000 -3,982,000        
      cash and cash equivalents and restricted cash, beginning of period
    		44,189,000 0 0 0 13,630,000 0 0 0 68,161,000 0 0 0 35,213,000 0 0 0 16,509,000 0 0 0 10,843,000 0 0 0 8,132,000         
      cash and cash equivalents and restricted cash, end of period
    		33,284,000 24,954,000 -15,095,000 19,611,000 14,719,000 -113,249,000 102,265,000 -10,529,000 35,143,000 -8,192,000 57,286,000 6,184,000 12,883,000 -106,116,000 52,855,000 63,642,000 24,832,000 -1,272,000 1,927,000 -25,969,000 41,823,000 -762,000 7,904,000 -3,877,000 7,578,000         
      supplemental information
    		                                 
      cash paid for interest
    		    47,000 60,000 70,000 88,000 104,000 122,000 141,000 147,000 144,000 145,000 147,000 125,000 73,000 73,000 30,000 32,000 35,000 38,000 39,000 38,000 34,000         
      non-cash interest expense
    		 0 0 19,000 26,000 33,000 40,000 49,000 56,000 61,000 67,000 74,000 72,000 69,000 67,000 81,000 44,000 41,000 32,000 32,000 35,000 38,000 43,000 44,000 44,000 44,000        
      loss on sale of property and equipment
    		 0 9,000 0 2,000 25,000 -2,000 13,000 57,000                         
      deferred income tax
    		     -67,000 6,000   -153,000            0 0 -253,000 -52,000         
      proceeds from sale of common stock and warrants, net of offering costs
    		     12,712,000    -79,000    -13,000                    
      proceeds from issuance of common stock to amgen
    		                                 
      cash paid for income taxes
    		                                 
      proceeds from sale of common stock, net of offering costs
    		  -1,000               0 0 -20,000 23,618,000             
      proceeds from exercise of stock options
    		  1,202,000 928,000 113,000 31,000 12,000 180,000 550,000 223,000 68,000 9,000 202,000 2,000 119,000   0 2,000               
      proceeds from issuance of common stock to horizon
    		                                 
      proceeds from borrowings, net of issuance costs
    		             0 0 0 5,000,000 0                
      discount in connection with issuance of debt
    		             -1,000 0 0 335,000         0        
      net decrease in cash and cash equivalents and restricted cash
    		       -10,529,000 -33,018,000                         
      right-of-use asset
    		        146,000 143,000 138,000 133,000 150,000 134,000 140,000 171,000 147,000                 
      lease liabilities
    		        -185,000 -335,000 -167,000 -164,000 -178,000 264,000 259,000 231,000 287,000 70,000 121,000               
      effect of exchange rate on cash, cash equivalents and restricted cash
    		        -14,000 -51,000 -13,000 -9,000 -15,000 93,000 14,000 64,000 -113,000                 
      proceeds from the sale of investments
    		                                 
      recognition of right-of-use asset
    		                 -494,000 -90,000 10,874,000 883,000             
      deferred tax asset
    		                                 
      gain on sale of property and equipment
    		                                 
      loss on sale of intangible asset
    		                     0 0           
      proceeds from sale of intangible asset
    		                     0 0           
      purchase of short-term investments
    		              -96,000 43,000 -4,914,000 -5,076,000 -14,502,000 -26,508,000 -13,296,000 -9,655,000 -21,818,000 -4,353,000 -37,037,000 -16,068,000        
      maturities of short-term investments
    		              1,999,000 9,212,000 18,100,000 9,950,000 25,500,000 9,000,000 31,125,000 18,800,000 37,800,000           
      proceeds from the sale of short-term investments
    		                 0 0 0 1,391,000    41,025,000         
      bargain purchase gain
    		                         -62,000        
      cash and cash equivalents acquired in connection with merger
    		                         0        
      proceeds from sale of preferred stock
    		                         0        
      convertible preferred stock exchanged for common stock
    		                         0        
      amortization of right-of-use asset
    		                  245,000               
      deferred rent and other
    		                    -213,000 -19,000 -15,000 -13,000 19,000 -11,000        
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		                  -7,000 4,000 -14,000             
      stock-based compensation and warrant expense
    		                   682,000 754,000 731,000 544,000 523,000 511,000         
      accounts payable
    		                    -973,000 1,276,000 -310,000 222,000 335,000 -858,000 2,030,000  -1,098,000 914,000 202,000 -558,000 204,000 
      accrued liabilities
    		                    1,079,000 -37,000 3,729,000 -1,000 204,000 -341,000        
      proceeds from borrowings
    		                         0        
      proceeds from exercise of stock options and common stock warrants
    		                     0 2,000 0 7,000 0        
      reclass of preferred stock warrant liability to equity
    		                         0        
      prepaid expenses
    		                        -27,000 -345,000        
      operating activities:
    		                                 
      common stock issued for intellectual property
    		                                 
      investing activities:
    		                                 
      purchase of property and equipment
    		                                 
      proceeds from sale short-term investments
    		                                 
      financing activities:
    		                                 
      cash and cash equivalents and restricted cash at beginning of period
    		                                 
      cash and cash equivalents and restricted cash at end of period
    		                                 
      depreciation and amortization
    		                                 
      depreciation
    		                            38,000 36,000 30,000  16,000 
      gain on sales of property and equipment
    		                                 
      prepaid expenses and other
    		                            -346,000 -99,000 -69,000 564,000 -427,000 
      accrued direct program expenses
    		                            95,000 133,000 1,054,000 98,000 -225,000 
      accrued restructuring charges
    		                                 
      accrued employee benefits
    		                            360,000 273,000 -963,000 339,000 359,000 
      accrued other liabilities
    		                            8,000 -25,000 -134,000 75,000  
      proceeds from sales of property and equipment
    		                                 
      purchases of marketable securities
    		                            -13,919,000 -22,766,000 -29,469,000 -41,179,000  
      proceeds from sales and maturities of marketable securities
    		                            22,200,000 28,650,000 27,550,000   
      proceeds from employee stock purchases and stock options exercised
    		                            11,000     
      net increase in cash and cash equivalents
    		                           8,035,000 752,000   -32,564,000 -42,966,000 
      cash and cash equivalents, beginning of period
    		                            0 0 24,991,000 0 0 
      cash and cash equivalents, end of period
    		                            752,000 -614,000 16,030,000 -32,564,000 -42,966,000 
      proceeds from issuance of common stock, net of offering costs
    		                               -1,000 -2,104,000 
      supplemental disclosures of cash flow information
    		                                 
      conversion of convertible preferred stock to common stock
    		                               0 0 
      net decrease in cash and cash equivalents
    		                              -8,961,000   
      description
    		                              2,016,000   
      assets measured at fair value:
    		                                 
      money market investments
    		                              7,592,000   
      u.s. treasury securities, obligations of u.s. government agencies, corporate debt securities and reverse repurchase agreements
    		                              70,182,000   
      depreciation and loss on disposal of assets
    		                                 
      change in value of preferred stock warrant liabilities and derivative
    		                                 
      amortization of deferred financing costs and noncash interest
    		                                 
      proceeds from issuance of convertible preferred stock
    		                                 
      decrease in restricted cash
    		                                 
      proceeds from notes payable
    		                                 
      principal payment on debt
    		                                 
      conversion of convertible debt and accrued interest to convertible preferred stock
    		                                 
      loss on disposal of assets
    		                                 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.